GHIT Fund Call for Proposals: Target Research Platform 2022
The Global Health Innovative Technology Fund (GHIT Fund) announces an investment opportunity for the Target Research Platform (TRP). TRP investments are intentionally broad in potential scope and focus on new technologies and novel approaches. Proposals must be within the project scope and investment eligibility below in order to be considered. The TRP is currently focused on technologies and approaches that address unmet or priority needs within malaria, tuberculosis and Neglected Tropical Diseases listed in the GHIT Intent to Apply form.
Proposed projects should be primarily originated from and be led by Japanese organizations and partnerships will need to be between eligible Japanese and non-Japanese organizations.
The GHIT Fund endeavors to facilitate collaboration and funding of global health technology R&D originating from Japan, to build momentum, and to demonstrate action and results. The Target Research Platform (TRP) is one of three platforms within the GHIT Fund’s Discovery Investment focus area. This platform is intended to support a crucial, earlier phase of R&D—discovery of new approaches, concepts, constructs and solutions to fight neglected infectious disease. To that end, proposals to the Target Research Platform should be innovative in nature and focused on early-stage discovery.
The proposed collaboration project may include, but is not limited to:
- Novel mechanisms of action for therapeutic targeting
- Pathogen component targeting to impact disease rather than infection
- Novel vaccine concepts, targets, and constructs
- New and improved approaches to diagnostic assays
Read more here.
Intent to apply deadline December 3, 2021.